Atrial fibrillation, commonly called AFib, is a heart rhythm disorder where the upper chambers of the heart (the atria) beat irregularly and often too quickly. Instead of a steady, coordinated beat, the atria quiver or fibrillate. This means blood doesn't flow through the heart as effectively as it should, and clots can form. According to the Centers for Disease Control and Prevention, approximately 2.7 to 6.1 million Americans have AFib, though many don't realize they have it.
Learn About Paying Your FGUA Bill Online →
The condition itself isn't always immediately life-threatening, but it carries real health risks. The most serious concern is stroke—people with AFib are about five times more likely to have a stroke than those without it. This happens because irregular heartbeats allow blood to pool in the heart, creating conditions where clots can form and travel to the brain. Beyond stroke risk, AFib can cause symptoms like fatigue, shortness of breath, chest discomfort, and a racing or fluttering sensation in the chest.
Understanding AFib treatment options matters because the approach isn't one-size-fits-all. Doctors consider factors like how long someone has had AFib, whether symptoms are bothersome, overall heart health, and stroke risk when deciding on treatment. Some people manage AFib with medication alone, while others benefit from procedures or devices. The goal of treatment typically includes two things: controlling heart rate so the heart can pump blood effectively, and reducing stroke risk.
Takeaway: AFib is manageable, but understanding your condition and available options is the first step. Different people need different approaches, so conversations with healthcare providers about your specific situation matter.
Medications form the foundation of AFib treatment for many people. There are two main categories: rate-control medications and rhythm-control medications. Rate-control drugs work by slowing down how fast the heart beats without necessarily restoring a normal rhythm. Rhythm-control medications, sometimes called antiarrhythmic drugs, attempt to restore and maintain a normal heart rhythm.
Free Guide to Pay by Plate Illinois Billing →
Rate-control medications include beta-blockers (such as metoprolol and atenolol), calcium channel blockers (like diltiazem and verapamil), and digoxin. These are often used first because they're well-established, generally have fewer side effects than rhythm-control drugs, and focus on the practical goal of making sure blood circulates adequately. A person taking rate-control medication might still have an irregular heartbeat, but the overall speed is managed so the heart can function reasonably well.
Rhythm-control medications include drugs like flecainide, sotalol, dofetilide, and amiodarone. These work differently—they try to restore normal rhythm or prevent AFib episodes from starting. However, they can have more noticeable side effects and sometimes require monitoring through blood tests and heart imaging. Amiodarone, for example, is powerful but can affect the thyroid and lungs, so people taking it need regular check-ups.
Nearly all people with AFib also take blood thinners (anticoagulants) to reduce stroke risk. These include warfarin (an older medication requiring frequent blood tests) and newer anticoagulants like apixaban, rivaroxaban, dabigatran, and edoxaban. The choice depends on kidney function, other medications, and individual factors.
Takeaway: Medications control AFib through different mechanisms—some slow the heart rate, others try to restore normal rhythm, and most people also take blood thinners. Knowing which category your medications fall into helps you understand what they're doing and why monitoring matters.
When medications don't work well enough or cause side effects that make them difficult to continue, catheter ablation offers another option. This is a procedure where a cardiologist uses thin wires (catheters) threaded through blood vessels to reach the heart. Once there, the doctor uses heat (radiofrequency ablation) or extreme cold (cryoablation) to create small scars in specific areas of heart tissue that are causing irregular signals.
Free Guide to Mold Removal Methods for Walls →
The procedure works because AFib often starts from rapid electrical signals originating in veins that bring blood back to the heart from the lungs (the pulmonary veins). By isolating these veins—essentially creating barriers so their signals don't trigger AFib—doctors can prevent many AFib episodes. The procedure typically takes two to four hours and is usually done under sedation or general anesthesia.
Success rates for catheter ablation vary depending on how long someone has had AFib and other heart conditions, but many studies show that between 60 to 80 percent of people are free from AFib recurrence after one procedure. Some people need a second procedure if AFib comes back. Importantly, even when ablation is successful, people typically continue taking blood thinners to prevent stroke, since the underlying tendency toward AFib may persist.
Risks of catheter ablation include bleeding, infection, perforation of the heart wall (rare but serious), damage to the esophagus (the tube carrying food to the stomach), and in very rare cases, stroke. However, these serious complications occur in less than 1 to 2 percent of procedures. Most people go home the same day or next day and return to normal activities within a few days.
Takeaway: Ablation is a procedure-based option that works for many people when medications aren't sufficient, with reasonable success rates and manageable risks when performed by experienced specialists.
For some people—particularly those having heart surgery for other reasons or those whose AFib hasn't responded to ablation—surgical approaches may be considered. The most common is the maze procedure, where a cardiac surgeon creates a pattern of scar tissue in the atria. This controlled scarring prevents chaotic electrical signals from traveling across the heart, forcing signals along a planned pathway that keeps the heart beating regularly.
How to Delete Your Fitbit Account Guide →
The maze procedure can be performed as open-heart surgery or through minimally invasive techniques where surgeons make small cuts rather than opening the entire chest. In some cases, it's done robotically. The procedure has strong evidence supporting its effectiveness—studies show success rates around 70 to 80 percent for eliminating AFib. It's often combined with other surgeries, like valve repair or bypass surgery.
Another surgical approach is pulmonary vein isolation performed during surgery, similar in principle to catheter ablation but done by surgeons during an open procedure. Left atrial appendage (LAA) closure is a surgical technique where surgeons close off a small pouch in the left atrium where blood clots often form during AFib. This is sometimes performed along with maze surgery or ablation in people with high stroke risk.
Surgical options generally carry more risk and longer recovery times than catheter ablation since they involve opening the chest. However, for people who haven't succeeded with less invasive options or who are already undergoing heart surgery, combining a surgical AFib treatment with the planned procedure can be efficient. Recovery typically involves several weeks of reduced activity and gradual return to normal functioning.
Takeaway: Surgery-based AFib treatments are generally reserved for specific situations but offer good success rates and may be combined with other needed heart procedures.
Recent technological advances have introduced devices designed to improve how we treat AFib. One significant category is implantable loop recorders (ILRs)—small devices about the size of a large vitamin placed under the skin of the chest. These continuously monitor heart rhythm and can detect AFib episodes that might otherwise go unnoticed, especially in people whose symptoms are subtle or who have paroxysmal AFib (episodes that come and go). The data helps doctors make better decisions about treatment.
Learn How to Grow Sweet Corn at Home →
Leadless pacemakers represent another advancement. Unlike traditional pacemakers with wires running through veins to the heart, leadless devices are implanted directly inside the heart. They're smaller, reduce infection risk, and cause fewer complications related to wire placement. For people with AFib who also need a pacemaker because their heart rate becomes too slow, these devices offer improvements over older technology.
Hybrid ablation is an emerging technique combining catheter ablation performed by an electrophysiologist with minimally invasive surgical ablation done
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.